LeMaitre Vascular Q3 2026 Earnings Date & Estimates

LeMaitre Vascular (NASDAQ:LMAT) is a medical device company that develops, manufactures and markets products used primarily in the treatment of peripheral vascular disease. Its products are designed for vascular surgeons and other specialists performing procedures on blood vessels outside the heart and brain, including procedures involving the carotid, lower-extremity and aortic vascular systems.

The company’s product portfolio includes biologic and synthetic vascular grafts, angioplasty and thrombectomy catheters, valvulotomes, carotid shunts, vascular clamps and other devices used in open and minimally invasive vascular surgery. LeMaitre also offers products intended to support vessel repair, bypass procedures and the management of vascular access and blood flow during surgery.

Headquartered in Burlington, Massachusetts, LeMaitre Vascular serves hospitals and healthcare providers in the United States and international markets through a combination of direct sales organizations and distributors. The company was founded in 1983 by George W. LeMaitre, who continues to serve as its chief executive officer.